Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2

Immunotherapy is a new and very pro­mising method of anti-cancer treat­ment. Unfortunately, not every patient can benefit from this treatment. The Polish drug program determines the selection of patients based on PD-L1 expression and the performance status assessed with the use of Eastern Cooperativ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Damian Mojsak, Beata Kuklińska, Michał Dębczyński, Robert Marek Mróz
Formato: article
Lenguaje:EN
Publicado: Termedia Publishing House 2021
Materias:
R
Acceso en línea:https://doaj.org/article/33951a72defa418a95258e7273536311
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!